This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignees: Surface Oncology, Inc., Adimab, LLC. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 13 
2 out of 52 
Years Active: 2020-2026
Title: Matthew Rausch: Innovator in Antibody Therapeutics
Introduction
Matthew Rausch is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of antibody therapeutics. With a total of 6 patents, Rausch has focused on developing innovative solutions for treating diseases, particularly cancer.
Latest Patents
Among his latest patents are the "Anti-IL-27 antibodies and uses thereof," which relates to anti-IL-27 antibodies and their potential applications in treating or ameliorating symptoms of diseases such as cancer. This patent also includes methods for detecting IL-27 in subjects or samples. Another notable patent is for "Anti-CD39 antibody compositions and methods," which provides compositions for anti-CD39 antibodies and their use in cancer treatment.
Career Highlights
Rausch has worked with several notable companies in the biotechnology sector, including Surface Oncology, Inc. and Adimab, LLC. His work in these organizations has contributed to advancements in cancer therapies and antibody development.
Collaborations
Matthew Rausch has collaborated with esteemed colleagues, including Scott C Chappel and Andrew Lake, further enhancing the impact of his work in the field.
Conclusion
Matthew Rausch's innovative work in antibody therapeutics showcases his dedication to advancing medical science and improving treatment options for patients. His contributions are significant in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile